Agfa at 22 euros
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BAYER, Germany's biggest drugs and chemicals company, yesterday said it priced shares in Agfa-Gevaert NV, its film-making unit, at 22 euros, the lower end of the range set to survey investor interest. The sale will raise 1.54 billion euros.
Bayer is selling 70 million shares, or half its stake in Agfa, the world's third-largest film maker. It had set a range of 21 euros to 26 euros to canvass investor interest.
The shares start trading in Frankfurt and Brussels today. Afga will join the Belgium blue-chip index, the Bel 20, on 11 June.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments